HOVANA is a digital biology company tackling translational dysfunction as a driver of serious diseases. Leveraging insights into cellular reprogramming, HOVANA is inventing a new class of genomic medicines that selectively block oncogene translation in hard-to-treat tumors. The company is led by a team whose work has generated 12 registered therapeutics, and founded by pioneers […]

Founded in 2022, Couragene is a biotechnology company developing first-in-class in vivo genetic therapies using its proprietary delivery platforms. The company’s technology holds potential for developing gene therapies for brain diseases. Couragene’s proprietary STEP (Stimuli-responsive Traceless Engineering Platform) technology was developed to leverage chemical engineering approaches to enable efficient intracellular delivery of genetic medicine payloads, […]

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond measuring gene sequence to measuring gene function, Function Oncology aims to identify optimal therapeutic opportunities for patients and advance the next generation of targeted cancer therapies. Function Oncology’s functional genomics […]